Nigeria’s battle with Lassa fever in 2026 is entering a more lethal phase, even as new confirmed infections taper. Health authorities warn that deeper systemic gaps — not just the virus itself — are driving a rising death toll that now outpaces last year’s trends.

The Nigeria Centre for Disease Control and Prevention (NCDC) reports that 167 deaths from Lassa fever have been recorded so far in 2026, a figure that continues an upward trajectory despite a recent downturn in newly confirmed cases. According to the agency’s Epidemiological Week 13 update, there were 26 new confirmed infections in the latest week, down from 51 the week before — yet the overall burden remains high, with 663 confirmed cases flagged across multiple states.

The cumulative fatality rate now stands at about 25.2%, significantly above levels seen during the same period in 2025, when the case fatality rate hovered around 18.5%.

Major Nigerian outlets such as ThisDay, PM News Nigeria, and Tribune Online report largely the same figures and emphasize the rise in deaths despite weekly case declines. However, broader reporting also highlights that multiple states beyond the traditional endemic zones are now reporting infections, underscoring a wider geographic spread than some reports imply. Coverage by AllAfrica indicates confirmed cases are cropping up in places like Plateau, Gombe, and Kogi, suggesting that transmission is not confined to core states alone.

What most reports do not fully explore is the gap between infection control capacity and the disease’s seasonal dynamics, nor the implications of persistent high fatality rates for long‑term public health strategy.

At first glance, a decline in new confirmed cases could be good news. But the high proportion of deaths relative to confirmed infections tells a different public health story. Even as new case counts ebb, late presentation, delays in diagnosis, and gaps in access to care appear to be limiting survival. This pattern — where outbreaks decline in spread but rise in lethality — points to systemic challenges rather than just seasonal infection cycles.

Two key factors driving this trend:

Delayed Health‑Seeking Behaviour: Many patients only present to health facilities at advanced stages of illness, reducing the effectiveness of early treatment.

Resource Constraints: Persistent challenges with surveillance, laboratory access, and timely referrals likely contribute to fatal outcomes. These operational bottlenecks were noted even earlier in the outbreak season, when transport costs and reporting inconsistencies were blamed for slower responses.

Additionally, the demographic profile remains consistent: young adults aged about 21–30 are most affected, a trend seen in previous weeks of reporting and consistent with seasonal outbreaks.

Lassa fever in Nigeria is known to be endemic with seasonal peaks, particularly during the dry season from November to May when human‑rodent contact increases. Public health surveillance data from earlier in the year confirms this pattern: Weeks 6–8 of 2026 showed fluctuating new cases and escalating death counts, with an increasing case fatality rate compared to the same time last year.

Earlier in the season, cases and deaths climbed steadily across states beyond the usual hotspots, and last month’s reports highlighted the inclusion of more regions in the outbreak map, indicating a wider geographic footprint than in previous years.

The NCDC has activated a multi‑partner incident management system, collaborating with WHO, UNICEF, MSF, and others to intensify surveillance, contact tracing, public education, and infection prevention strategies. Authorities continue to press state governments to maintain community engagement and encourage early care‑seeking.

Despite no fresh healthcare worker infections this latest week, the enduring high fatality ratio suggests that clinical management, referral systems, and early detection capabilities remain insufficient in many areas.

The rising fatality rate in the midst of declining weekly cases signals a concerning disconnect: fewer new diagnoses but more deaths. Unless Nigeria improves early detection, access to supportive care, and community awareness, the outbreak could continue to claim lives disproportionately — even if overall transmission cools. Robust, sustained investment in public health infrastructure will be critical not just this season, but for managing future outbreaks.